Hing C. Wong
Impact in
- Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Virology top 2%
- HIV Research and Treatment
Papers in
- Immunology 67
- Immune Cell Function and Interaction 53
- T-cell and B-cell Immunology 24
- Immunotherapy and Immune Responses 17
- Oncology 57
- CAR-T cell therapy research 42
- Cancer Immunotherapy and Biomarkers 16
- Co-authors
- Emily K. JengPeter R. RhodeN. Rama KrishnaH.R. WhiteleyH E SchnepfThangiah GeethaMarie W. WootenJeganathan Ramesh Babu
- Journals
- Journal of Clinical Oncology (11 papers)The Journal of Immunology (10 papers)Cancer Research (8 papers)Journal of Bacteriology (6 papers)Blood (6 papers)
- Partner nations
- United StatesItalyChina
In The Last Decade
Hing C. Wong
120 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Immunology 2.8k
- Virology 406
- Oncology 2.0k
- Biotechnology 351
- Molecular Biology 2.2k
Countries citing papers authored by Hing C. Wong
This map shows the geographic impact of Hing C. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hing C. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hing C. Wong more than expected).
Fields of papers citing papers by Hing C. Wong
This network shows the impact of papers produced by Hing C. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hing C. Wong. The network helps show where Hing C. Wong may publish in the future.
Co-authors
The 25 scholars most cited alongside Hing C. Wong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 20 | |
| 2 | 2018 | 7 | |
| 3 | 2018 | 146 | |
| 4 | Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery Hit paper breakdown → | 2018 | 542 |
| 5 | 2017 | 1 | |
| 6 | 2017 | 17 | |
| 7 | 2016 | 30 | |
| 8 | 2016 | 1 | |
| 9 | 2015 | 74 | |
| 10 | 2015 | 170 | |
| 11 | 2013 | 157 | |
| 12 | 2012 | 45 | |
| 13 | 2012 | 34 | |
| 14 | 2009 | 123 | |
| 15 | 2007 | 1 | |
| 16 | 2006 | 24 | |
| 17 | 2005 | 65 | |
| 18 | 2005 | 26 | |
| 19 | A novel soluble single-chain T-cell receptor IgG1 fusion protein retains MHC restricted peptide specific antigen binding and exhibits anti-tumor effects in vivo. | 2004 | 1 |
| 20 | 1998 | 2 |
About Hing C. Wong
Hing C. Wong is a scholar working on Immunology, Oncology, Virology, Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 124 papers that have together received 6.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (53 papers), CAR-T cell therapy research (42 papers), T-cell and B-cell Immunology (24 papers), Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (16 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Lymphoma Diagnosis and Treatment (11 papers) and Bladder and Urothelial Cancer Treatments (11 papers). The work is most often cited by research in Immunology (2.8k citations), Virology (406 citations), Oncology (2.0k citations), Biotechnology (351 citations) and Molecular Biology (2.2k citations). Hing C. Wong has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Emily K. Jeng, Peter R. Rhode, N. Rama Krishna, H.R. Whiteley, H E Schnepf, Thangiah Geetha, Marie W. Wooten, Jeganathan Ramesh Babu, M. Lamar Seibenhener and Xiaoyun Zhu. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology, Cancer Research, Journal of Bacteriology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.